BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35889222)

  • 1. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.
    Cucielo MS; Cesário RC; Silveira HS; Gaiotte LB; Dos Santos SAA; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.
    Zemła A; Grzegorek I; Dzięgiel P; Jabłońska K
    In Vivo; 2017; 31(5):801-809. PubMed ID: 28882945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the MT1 melatonin receptor in ovarian cancer cells.
    Jablonska K; Pula B; Zemla A; Kobierzycki C; Kedzia W; Nowak-Markwitz E; Spaczynski M; Zabel M; Podhorska-Okolow M; Dziegiel P
    Int J Mol Sci; 2014 Dec; 15(12):23074-89. PubMed ID: 25514412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin antagonizes oxidative stress-induced mitochondrial dysfunction in retinal pigmented epithelium cells via melatonin receptor 1 (MT1).
    Yan G; Yu L; Jiang S; Zhu J
    J Toxicol Sci; 2018; 43(11):659-669. PubMed ID: 30404999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
    Treeck O; Haldar C; Ortmann O
    Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin enhances cell death and suppresses the metastatic capacity of ovarian cancer cells by attenuating the signaling of multiple kinases.
    Cucielo MS; Freire PP; Emílio-Silva MT; Romagnoli GG; Carvalho RF; Kaneno R; Hiruma-Lima CA; Delella FK; Reiter RJ; Chuffa LGA
    Pathol Res Pract; 2023 Aug; 248():154637. PubMed ID: 37356221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteomic landscape of ovarian cancer cells in response to melatonin.
    Cesário RC; Gaiotte LB; Cucielo MS; Silveira HS; Delazari Dos Santos L; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
    Life Sci; 2022 Apr; 294():120352. PubMed ID: 35074409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Bicer E; Bese T; Tuzun DD; Ilvan S; Kayan BO; Demirkiran F
    Int J Gynecol Pathol; 2024 Mar; 43(2):190-199. PubMed ID: 37922887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
    González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
    Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
    Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.
    Carbajo-Pescador S; García-Palomo A; Martín-Renedo J; Piva M; González-Gallego J; Mauriz JL
    J Pineal Res; 2011 Nov; 51(4):463-71. PubMed ID: 21718361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.
    Wang X; Sirianni A; Pei Z; Cormier K; Smith K; Jiang J; Zhou S; Wang H; Zhao R; Yano H; Kim JE; Li W; Kristal BS; Ferrante RJ; Friedlander RM
    J Neurosci; 2011 Oct; 31(41):14496-507. PubMed ID: 21994366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1.
    Huang B; Qian C; Ding C; Meng Q; Zou Q; Li H
    Stem Cell Res Ther; 2019 Nov; 10(1):362. PubMed ID: 31783916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted melatonin photorelease supports the presence of melatonin MT1 receptors in mitochondria inhibiting respiration.
    Somalo-Barranco G; Pagano Zottola AC; Abdulrahman AO; El Zein RM; Cannich A; Muñoz L; Serra C; Oishi A; Marsicano G; Masri B; Bellocchio L; Llebaria A; Jockers R
    Cell Chem Biol; 2023 Aug; 30(8):920-932.e7. PubMed ID: 37572668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
    Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
    Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors.
    Goyal R; Gupta T; Bal A; Sahni D; Singh G
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):518-523. PubMed ID: 31290783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
    Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
    Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of melatonin receptor 1 and induction of follicle-stimulating hormone on the regulation of mouse granulosa cell function.
    Talpur HS; Worku T; Rehman ZU; Dad R; Bhattarai D; Bano I; Farmanullah ; Liang A; He C; Yang L
    Reprod Biol; 2017 Dec; 17(4):380-388. PubMed ID: 29097083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.